OA03.03 Datopotamab Deruxtecan (Dato-DXd; DS-1062), a TROP2 ADC, in Patients With Advanced NSCLC: Updated Results of TROPION-PanTumor01 Phase 1 Study

Authors:
  • ASA. Spira
    A. Spira
  • ALA. Lisberg
    A. Lisberg
  • JSJ. Sands
    J. Sands
  • JGJ. Greenberg
    J. Greenberg
  • PPP. Phillips
    P. Phillips
  • FGF. Guevara
    F. Guevara
  • NTN. Tajima
    N. Tajima
  • YKY. Kawasaki
    Y. Kawasaki
  • JGJ. Gu
    J. Gu
  • FKF. Kobayashi
    F. Kobayashi
  • NYN. Yamamoto
    N. Yamamoto
  • MJM. Johnson
    M. Johnson
Publisher website
Google Scholar
Abstract
No abstract available